期刊文献+

多重耐药鲍曼不动杆菌感染的相关危险因素分析 被引量:13

Analysis of related risk factors of multidrug-resistant acinetobacter baumannii infection
下载PDF
导出
摘要 目的探讨多重耐药鲍曼不动杆菌(MDRAB)的相关危险因素,为临床合理用药提供依据。方法采用回顾性分析方法调查2016年1月至2017年12月新疆生产建设兵团系统内13家医疗机构的1359例鲍曼不动杆菌感染病人的病例资料,得出感染MDRAB的危险因素,并通过多元logistic回归分析发现独立危险因素。结果1359例鲍曼不动杆菌感染病人中老年人(75~99岁)居多有664例(占48.86%),科室分布以内科为主有916例(占67.40%),感染部位主要分布在呼吸系统有1129例(占83.08%),标本类型主要为痰液有1101例(占81.02%),多重耐药组死亡265例,病死率35.71%;非多重耐药组死亡134例,病死率21.72%。两组比较差异有统计学意义(χ2=31.819,P=0.000)。单因素分析结果显示:性别、长期卧床、两种以上基础疾病、手术、侵入操作、入住ICU、心功能不全、肝功能不全、肾功能不全、肺功能不全、合并其它细菌感染、合并真菌感染、免疫调节剂使用、喹诺酮类使用、糖肽类使用、碳青霉烯类使用、加酶抑制剂使用是MDRAB感染的危险因素。多因素分析结果显示:是否入住ICU、侵入操作、喹诺酮类使用、碳青霉烯类使用、加酶抑制剂使用是MDRAB感染的独立危险因素。结论MDRAB给临床治疗带来了极大的挑战,早期干预危险因素及合理使用抗菌药物有助于减少MDRAB的发生率。 Objective To explore the risk factors of multidrug resistant Acinetobacter baumannii(MDRAB),and to provide evi⁃dence for rational drug use in clinic.Methods The data of 1359 patients with Acinetobacter baumannii(AB)infection in 13 med⁃ical institutions of the corps system from January 2015 to December 2016 were investigated by retrospective analysis method,and the risk factors of MDRAB infection were obtained.The independent risk factors were found through multiple logistic regression analysis.Results In 1359 cases of medical records,the majority of patients with AB infection were the elderly(75⁃99 years old)(48.86%),the department distribution was mainly internal medicine(67.40%),the infection site was mainly respiratory system(83.08%),the specimen type was mainly sputum(81.02%),and the mortality rate of multidrug resistance group was significantly higher than that of non⁃multidrug resistance group(P=0.000).Single factor analysis showed that gender,long⁃term bedridden,two or more basic diseases,surgery,invasive procedures,ICU admission,cardiac insufficiency,hepatic insufficiency,renal insufficiency,pulmonary dysfunction,concomitant with other bacterial infection,the combining fungal infections,immune regulator use,quinolone use,sugar peptide use,carbapenem use,plus enzyme inhibitor use were MDRAB infection risk factors.The results of multivariate analysis showed that the presence of ICU,invasive procedures,quinolone use,carbapenem use and enzyme inhibitor use were inde⁃pendent risk factors for MDRAB infection.Conclusion MDRAB poses great challenges to clinical treatment.Early intervention of risk factors and rational use of antimicrobial agents can help reduce the incidence of MDRAB.
作者 李娜 刘晓霞 LI Na;LIU Xiaoxia(Department of Pharmacy,Xinjiang Production and Construction Corps Hospital,Urumqi,Xingjing Uygur Autonomous Region 830002,China)
出处 《安徽医药》 CAS 2020年第1期197-201,共5页 Anhui Medical and Pharmaceutical Journal
基金 新疆生产建设兵团工业科技计划项目(2015AB034)
关键词 鲍曼不动杆菌 抗药性 多种 细菌 危险因素 合理用药 Acinetobacter baumannii Drug resistance multiple bacterial Risk factors Rational drug use
  • 相关文献

参考文献15

二级参考文献152

  • 1王艳丽,黄茂,梅亚宁,殷凯生.鲍曼不动杆菌对喹诺酮类药物的耐药机制研究[J].中国感染与化疗杂志,2008,8(4):266-270. 被引量:24
  • 2周颖杰,李光辉.成人及儿童复杂性腹腔内感染的诊断与处理:美国外科感染学会及美国感染病学会指南[J].中国感染与化疗杂志,2010,10(4):241-247. 被引量:240
  • 3赵培革,李艳华,徐俊萍,葛翠云.耐药鲍曼不动杆菌所致老年医院获得性肺炎相关因素[J].中国老年学杂志,2014,34(5):1360-1362. 被引量:11
  • 4周月清,陆开来,糜祖煌.鲍曼不动杆菌TEM基因及氨基糖苷类修饰酶基因初步研究[J].中华检验医学杂志,2005,28(2):200-202. 被引量:64
  • 5Arias CA, Murray BE. Antibiotic-resistant bugs in the 21st century-a clinical super-challenge[J]. N Engl J Med, 2009, 360(5) : 439-443.
  • 6Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing[S]. Tweenty-first in- formational supplement, 2011, M100-S21 Vol 31 No. 1.
  • 7Falagas ME, Giannopoulou KP, Kokolakis GN, et al. Fosfo- mycin: use beyond urinary tract and gastrointestinal infec tions[J]. Clin Infect Dis, 2008, 46(7): 1069-1077.
  • 8Olsson-Liljequist B, Burman LG. Introducing fosfomycin for surgical prophylaxis-emergence of resistance in aerobic faecal gram-negative bacteria of in patients, but not among strains causing infection after elective colorectal procedures [J ]. Scand J Infect Dis, 1993, 25(6) :725-733.
  • 9Andaker L, Burman LG, Eklund A, et al. Fosfomycin/met- ronidazole compared with doxycycline/metronidazole for the prophylaxis of infection after elective coloreetal surgery: a randomised double blind multicentre trial in 517 patients[J]. Eur J Surg, 1992, 158(3):181 185.
  • 10Nohr M, Andersen JC, Juul-Jensen KE. Prophylactic single dose fosfomycin and metronidazole compared with neomycin, haeitraein, metronidazole and ampicillin in elective colorectal operations[J]. Acta Chir Seand, 1990, 156(3):223-230.

共引文献8127

同被引文献134

引证文献13

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部